Advisory Services Network, LLC Rigel Pharmaceuticals Inc Transaction History

Advisory Services Network, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$0.72 - $1.56 $1,944 - $4,212	2,700 New	2,700 $3,000
Q4 2022 Feb 13, 2023	BUY	$0.67 - $11.9 $1,340 - $23,800	2,000 New	2,000 $3,000
Q3 2021 Nov 05, 2021	SELL	$3.5 - $4.5 $437 - $562	-125 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$3.09 - $4.54 $386 - $567	125 New	125 $1,000
Q1 2021 May 24, 2021	SELL	$3.35 - $4.93 $418 - $616	-125 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$2.35 - $3.74 $484 - $770	-206 Reduced 62.24%	125 $0
Q3 2020 Nov 16, 2020	BUY	$1.78 - $4.13 $589 - $1,367	331 New	331 $1,000
Q2 2020 Aug 10, 2020	SELL	$1.41 - $2.05 $290 - $422	-206 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$1.6 - $2.43 $329 - $500	206 New	206 $0

335K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $3.72B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.